Whether HIV or COVID-19, Pregnant or Lactating Cisgender Women Need to Be Included in Clinical Trials for Therapies
Dr. Shahin Lockman says to not include women in trials is unethical.
Retire? No, Thanks! This Doc Instead Moved to West Virginia to Fight HIV, Hepatitis C, and the Opioid Crisis
In a poor and conservative state, Judith Feinberg, M.D., aims to expand harm reduction—and bring treatment to active drug users.
Using data from the ADVANCE trial, this researcher suggests people with HIV with low-level viremia may still get to undetectable.
One New York-based provider who works specifically with trans and gender non-conforming patients outlines what needs to change in the health care world to get Black trans women the care they deserve.
Steven Deeks, M.D., talks about the medical community's hopes, inspirations, and unanswered questions regarding research for an HIV cure.
In a field of research as rapidly evolving as HIV, new developments come fast and furious; anticipating the research that’s most likely to make waves can be a challenge. That’s why we turn to experts for their thoughts, predictions and educated guesses.
Much of your research has focused on the systems through which people receive medical care and how those systems affect the actual outcomes of care in terms of, say, fewer hospital days or improved quality of life. In a broad sense, this kind of rese...